ETFS SP (Australia) Odds of Future Etf Price Finishing Over 54.06
| CURE Etf | 47.54 0.47 0.98% |
ETFS |
ETFS SP Target Price Odds to finish over 54.06
The tendency of ETFS Etf price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over 54.06 or more in 90 days |
| 47.54 | 90 days | 54.06 | near 1 |
Based on a normal probability distribution, the odds of ETFS SP to move over 54.06 or more in 90 days from now is near 1 (This ETFS SP Biotech probability density function shows the probability of ETFS Etf to fall within a particular range of prices over 90 days) . Probability of ETFS SP Biotech price to stay between its current price of 47.54 and 54.06 at the end of the 90-day period is about 97.0 .
Assuming the 90 days trading horizon ETFS SP has a beta of 0.0891 suggesting as returns on the market go up, ETFS SP average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding ETFS SP Biotech will be expected to be much smaller as well. Additionally ETFS SP Biotech has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. ETFS SP Price Density |
| Price |
Predictive Modules for ETFS SP
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ETFS SP Biotech. Regardless of method or technology, however, to accurately forecast the etf market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the etf market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.ETFS SP Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. ETFS SP is not an exception. The market had few large corrections towards the ETFS SP's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ETFS SP Biotech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ETFS SP within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.11 | |
β | Beta against Dow Jones | 0.09 | |
σ | Overall volatility | 1.32 | |
Ir | Information ratio | -0.06 |
ETFS SP Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ETFS SP for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ETFS SP Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| ETFS SP Biotech generated a negative expected return over the last 90 days | |
| Latest headline from news.google.com: Stockpickers Indivior highlights the difficulty of finding a cure - Financial Times |
ETFS SP Technical Analysis
ETFS SP's future price can be derived by breaking down and analyzing its technical indicators over time. ETFS Etf technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of ETFS SP Biotech. In general, you should focus on analyzing ETFS Etf price patterns and their correlations with different microeconomic environments and drivers.
ETFS SP Predictive Forecast Models
ETFS SP's time-series forecasting models is one of many ETFS SP's etf analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary ETFS SP's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the etf market movement and maximize returns from investment trading.
Things to note about ETFS SP Biotech
Checking the ongoing alerts about ETFS SP for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for ETFS SP Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| ETFS SP Biotech generated a negative expected return over the last 90 days | |
| Latest headline from news.google.com: Stockpickers Indivior highlights the difficulty of finding a cure - Financial Times |
Other Information on Investing in ETFS Etf
ETFS SP financial ratios help investors to determine whether ETFS Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ETFS with respect to the benefits of owning ETFS SP security.